EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lathyrol Targets G6PD to Disrupt Redox Homeostasis in Non-Small Cell Lung Cancer

Zhaoxuan Li iD, Linlin Zhang, Xueyan Zhen, Xinglu Liu, Yan Ren iD, Wei Jia

ACS Omega · 04.08.2026 · 11 (30) · 45176-45185

DOI: 10.1021/acsomega.6c03709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 20.07.2026. Verfasst von Zhaoxuan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Study on the Impact of KEAP1 Mutation on Drug Resistance in Lung Cancer and the Synergistic Effect of ML385 in Chemotherapy, Significance of KEAP1 Gene Mutation in Non-Small Cell Lung Cancer, ?Strengthening Traditional Chinese Medicine Excellence? Initiative (Phase II) of the Shanghai Hongkou District Health Commission.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lathyrol, a bioactive natural compound derived from plants of the Euphorbiaceae family, exhibits antitumor activity, and its molecular targets and underlying mechanisms remain incompletely understood. In this study, thermal proteome profiling (TPP) was applied to systematically identify lathyrol-binding proteins in non-small cell lung cancer (NSCLC) cells. TPP analysis identified glucose-6-phosphate dehydrogenase (G6PD) as a candidate target of lathyrol. A cellular thermal shift assay (CETSA) confirmed increased thermal stability of G6PD upon treatment. Molecular docking indicated a potential interaction between lathyrol and G6PD. The peptide-centric local stability assay (PELSA) revealed localized conformational changes in the C-terminal region of G6PD consistent with the predicted interaction interface. Enzymatic assays showed reduced G6PD activity accompanied by decreased intracellular NADPH levels. Quantitative proteomics indicated alterations in the pathways associated with glucose metabolism and redox regulation. These findings identify G6PD as a functional target of lathyrol in NSCLC cells and link its inhibition to disruption of cellular redox balance and metabolic homeostasis.

Autor:innen und Institutionen

  • Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Shanghai Integrated Traditional Chinese and Western Medicine Hospital, Shanghai 200082, China.
  • Shanghai University of Traditional Chinese Medicine, Science and Technology Experimental Center, Shanghai 201203, China.

ORCID-Profile: Zhaoxuan Li, Yan Ren

Förderung

  • Study on the Impact of KEAP1 Mutation on Drug Resistance in Lung Cancer and the Synergistic Effect of ML385 in Chemotherapy
  • Significance of KEAP1 Gene Mutation in Non-Small Cell Lung Cancer
  • ?Strengthening Traditional Chinese Medicine Excellence? Initiative (Phase II) of the Shanghai Hongkou District Health Commission
  • Clinical Key Specialty Support Program of the Shanghai Hongkou District Health Commission
  • Development and Validation of a Prediction Model for Benign versus Malignant Subsolid Pulmonary Nodules

Zitieren

APA

Li, Z., Zhang, L., Zhen, X., Liu, X., Ren, Y., & Jia, W. (2026). Lathyrol Targets G6PD to Disrupt Redox Homeostasis in Non-Small Cell Lung Cancer. ACS Omega, 11(30), 45176-45185. https://doi.org/10.1021/acsomega.6c03709

Vancouver

Li Z, Zhang L, Zhen X, Liu X, Ren Y, Jia W. Lathyrol Targets G6PD to Disrupt Redox Homeostasis in Non-Small Cell Lung Cancer. ACS Omega. 2026;11(30):45176-45185. doi:10.1021/acsomega.6c03709

BibTeX
@article{Li2026,
  author = {Li, Zhaoxuan and Zhang, Linlin and Zhen, Xueyan and Liu, Xinglu and Ren, Yan and Jia, Wei},
  title = {Lathyrol Targets G6PD to Disrupt Redox Homeostasis in Non-Small Cell Lung Cancer},
  journal = {ACS Omega},
  year = {2026},
  volume = {11},
  number = {30},
  pages = {45176--45185},
  doi = {10.1021/acsomega.6c03709}
}
Kostenlos starten →